First reported at 79,970 shares this quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2022-06-30 | 534000 |
| 2022-09-30 | 389000 |
| 2022-12-31 | 367984 |
| 2023-03-31 | 301967 |
| 2023-06-30 | 221215 |
| 2023-09-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2023 | Reduced | 0 | -66,232 (-100.0%) | 0 | $0 | 2023-11-14 | |
| Q2 2023 | Reduced | 66,232 | -6,531 (-9.0%) | < 0.01% | $221,215 | 2023-08-14 | |
| Q1 2023 | Unchanged | 72,763 | 0 (0.0%) | < 0.01% | $301,967 | 2023-05-15 | |
| Q4 2022 | Added | 72,763 | +42 (0.1%) | < 0.01% | $367,984 | 2023-02-10 | |
| Q3 2022 | Reduced | 72,721 | -7,249 (-9.1%) | < 0.01% | $389,000 | 2022-11-14 | |
| Q2 2022 | New | 79,970 | +79,970 (0.0%) | < 0.01% | $534,000 | 2022-08-12 |
Who else reported the position
14 managers reported DIFFUSION PHARMACEUTICALS I for Q2 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC This report | New | 79,970 | +79,970 | < 0.01% | $534,000 | 1 qtr |
| RENAISSANCE TECHNOLOGIES LLC | New | 48,773 | +48,773 | < 0.01% | $326,000 | 1 qtr |
| BlackRock Inc | New | 32,852 | +32,852 | < 0.01% | $219,000 | 1 qtr |
| GEODE CAPITAL MANAGEMENT LLC | New | 17,165 | +17,165 | < 0.01% | $112,000 | 1 qtr |
| BRIDGEWAY CAPITAL MANAGEMENT LLC | New | 16,565 | +16,565 | < 0.01% | $109,000 | 1 qtr |
| Trexquant Investment LP | New | 10,631 | +10,631 | < 0.01% | $71,000 | 1 qtr |
| MORGAN STANLEY | New | 548 | +548 | < 0.01% | $4,000 | 1 qtr |
| ADVISOR GROUP HOLDINGS INC | New | 600 | +600 | < 0.01% | $4,000 | 1 qtr |
| UBS Group AG | New | 430 | +430 | < 0.01% | $3,000 | 1 qtr |
| Tower Research Capital LLC TRC | New | 245 | +245 | < 0.01% | $2,000 | 1 qtr |
Filing details and methodology As reported
- Report period
- June 30, 2022
- Filed
- August 12, 2022
- Filing type
- 13F-HR
- Position type
- COM NEW
Voting authority reported
- Sole
- 0
- Shared
- 0
- None
- 79,970
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.